PMDA drug package insert
ゾニサミドOD錠25mgTRE「SMPP」
PMDA Prescription drug · 住友ファーマプロモ株式会社 · package insert Feb 20, 2024
Key facts
| Brand names | ゾニサミドOD錠25mgTRE「SMPP」, ゾニサミドOD錠50mgTRE「SMPP」 |
|---|---|
| Nonproprietary names | ゾニサミド |
| Companies | 製造販売元／住友ファーマプロモ株式会社, 販売元／住友ファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | パーキンソン病治療薬・レビー小体型認知症に伴うパーキンソニズム治療薬（レボドパ賦活剤）（OD錠25mg）; パーキンソン病治療薬（レボドパ賦活剤）（OD錠50mg） |
| Therapeutic category codes | 871169 |
| YJ codes | 1169015F2030, 1169015F3037 |
| Approval numbers | 30500AMX00184000, 30500AMX00185000 |
| Package insert edition | 第3版 |
| Package insert date | Feb 20, 2024 |
| PMDA document key | 370242_1169015F2030_1 |
| PMDA company code | 370242 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: